ROARABLE
FREE $100K
My Trading Account →
▾
Trading Account Active
Verified Trader
⚡ My $100K Trading Account → ★ My Saved Watchlist →
🟢 My $100K Account → Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / ETF / Index / XLV
DIA (65) JEPI (62) XLE (76) XLF (74) ⌘ Pro Terminal →

Health Care Select Sector SPDR Fund (XLV) — RQD Stock Rating Cockpit

$184.60 +0.45% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $185.19

Health Care Select Sector SPDR Fund (XLV) earns a Roarable Rating of B+ (Buy) with 79/100 RQD Confidence. As an exchange-traded fund, single-company GAAP gross margins, Altman-Z, and CEO Form 4 insider metrics are N/A for fund structure; its score reflects basket trend, institutional flow, and macro regime alignment.

ROARABLE B+ • BUY Cap $40.00B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on XLV Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is XLV stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Health Care Select Sector SPDR Fund (NYSE: XLV) is rated B+ (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 79/100 at a spot price of $184.60 (+0.45% 1D, market cap $40.00B). Pillar breakdown: Fundamental Cash Engine 20/20, Institutional 13F & Options Flow 15/20, SEC Balance-Sheet Forensics 18/20, FRED Macro Regime Fit 11/20, and Executive Insider Alignment 15/20. Across 40 tracked ETF / Index issuers, XLV ranks #2 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does XLV compare to DIA and JEPI in the ETF / Index sector?
▼

Within the ETF / Index sector (GICS Health Care & Pharma), XLV carries a Roarable B+ (79/100 RQD), trailing P/E of N/A, gross margin of N/A (ETF), and ROIC of N/A (ETF). By comparison, DIA (SPDR Dow Jones Industrial Average ETF) holds a C grade (65/100 RQD, P/E N/A, ROIC —, cap $38.00B) and JEPI (JPMorgan Equity Premium Income ETF) posts a C grade (62/100 RQD, P/E N/A, ROIC —, cap $37.00B). Among the 5-stock peer group, XLV leads on earnings multiple (N/A) while XLV leads on capital efficiency (— ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for XLV?
▼

For Health Care Select Sector SPDR Fund (XLV), key quantitative strengths include Diversified GICS Health Care & Pharma basket eliminates single-company earnings blowup risk and Institutional 13F desks and index options flow show constructive basket demand., while primary risk factors center on Corporate GAAP gross margin, Altman-Z, and Form 4 insider metrics are N/A for ETF fund structures and Underlying index basket remains sensitive to Federal Reserve liquidity and Treasury yield swings.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $185.19 (+0.32%)🧬 ETF Open-End Share Creation/Redemption⚙️ Cash Engine: 20/20 (A+) • Liquid Basket
Verify 90D Bucket Audit →
📊 Historical Track Record: Scores of 79/100 (B+) historically ranked in the Top 9% of excess returns over the next 90 days (+8.1% avg 90D alpha vs SPY • 71.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERBUY • B+
025507510079
3-of-3 JEV AI Jury Bullish
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw A- · Rk B
Fund (20)Whales (15)Struct (18)Macro (11)Flow (15)
Each axis scored 0–20
12M PRICE TARGET CONE+9.4% Base Target
$238 Bull$202 Base$151 Bear
📬 FREE XLV RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for XLV)Realized 20D OHLCV Swing Band: ±3.5%
Deterministic 5-Pillar Attribution (79/100 Composite)
🔍 WHY XLV SCORES 79/100 (B+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Cash Engine Quality+20/20 pts (25% of score)

ETF liquidity & tracking efficiency ($40.00B AUM)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+18/20 pts (23% of score)

Diversified basket structure mitigates single-issuer 10-K restatement risk

▼ #1 Drag / Risk Factor: Macro Regime Fit11/20 pts (-9 pt drag)

Macro rate sensitivity & RSI-14 (71.4) create a -9 pt regime headwind

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
71
Grade B$173.96+2.9% Next Q
Q2 (-2Q)
74
Grade B+$178.94+0.4% Next Q
Q3 (-1Q)
76
Grade B+$179.72+2.7% Next Q
Current
79
Grade B+$184.60+8.1% Hist 90D α
Trajectory: B (71) → B+ (79)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the XLV Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 79/100 (B+) score, XLV faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Corporate GAAP gross margin, Altman-Z, and Form 4 insider metrics are N/A for ETF fund structures.

⚠️ Forensic Kill-Switch #2

Underlying index basket remains sensitive to Federal Reserve liquidity and Treasury yield swings.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($172.81) or 200D SMA ($159.10) invalidates the momentum regime and cuts Target Base ($202.04) toward Bear Floor ($151.37).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $XLV• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “XLV Beats Next Quarter EPS Consensus (Quarterly Rebalance / Distribution) & Holds Above 200D SMA”
YES 79%NO 21%Trade / Inspect Odds →
RSI-14 MOMENTUMOVERBOUGHT (>70)
71.430 Oversold · 70 Hot
ALTMAN-Z SHIELDETF / Index Composite — N/A for Fund Structure
N/A (ETF)Fund Structure
PIOTROSKI F-SCOREETF / Index Composite — N/A for Fund Structure
N/A (ETF)Fund Structure
52-WEEK LASER RANGE93% OF RANGE
L: $142$184.60H: $188
1. Basket Liquidity & Structure● HEALTHY
ETF / Index composite efficiency

ETF / Index Composite — N/A for corporate GAAP gross margins; reflects underlying basket liquidity and structure.

Factor Grade: A+RQD 20 / 20
2. Institutional Basket Flow● BUYING
13F & index options positioning

Tracks institutional 13F ETF basket allocations and index options positioning (corporate CEO Form 4 rules N/A for fund structure).

Factor Grade: BRQD 30 / 40
3. Hidden Risks & Market Weather● ALL CLEAR
Macro regime & rate sensitivity

Evaluates index basket sensitivity to Federal Reserve liquidity and Treasury yield shifts (corporate 10-K Altman-Z / Piotroski checks N/A for ETF structure).

Factor Grade: BRQD 29 / 40
MULTI-MODEL JEV QUANT JURY DELIBERATION

3-of-3 JEV AI Jury Bullish on XLV

Cash & Moat Bull AI
Index Basket & Yield Model
BULLISH (98)

ETF / Index Composite — N/A for Fund Structure (single-company ROIC and GAAP gross margin do not apply to index funds).

SEC Forensic Auditor AI
Fund Structure & Liquidity Guard
BULLISH (90)

ETF / Index Composite — N/A for Fund Structure (corporate Altman-Z and Piotroski 9-point checks do not apply to ETFs).

Whale & Macro Hawk AI
Options Skew, 13F & Fed NetLiq
BULLISH (68)

30/40 institutional & smart-money positioning score with 11/20 macro alignment.

Bull Case: Why Buyers Like XLV
  • ✓Diversified GICS Health Care & Pharma basket eliminates single-company earnings blowup risk.
  • ✓Institutional 13F desks and index options flow show constructive basket demand.
  • ✓Deep intraday secondary-market liquidity with transparent underlying index holdings.
Bear Case: What Could Go Wrong
  • !Corporate GAAP gross margin, Altman-Z, and Form 4 insider metrics are N/A for ETF fund structures.
  • !Underlying index basket remains sensitive to Federal Reserve liquidity and Treasury yield swings.
  • !Broad market drawdowns affect index vehicles in lockstep with constituent weights.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (XLV Tape Review)

  • ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
  • ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
  • ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
XLV // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +27.55%▲ ASCENDING CHANNEL
2026-11-03O $183.8H $184.6L $183.8C $184.6VOL 18.67M
RES: $188.7SUP: $167.9SMA50: $172.8SMA200: $159.1
$191.2$178.0$164.9$151.7$138.6RES $188.7SUP $167.9$184.62026-05-042026-06-182026-08-052026-09-212026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

XLV Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 XLV Butterfly Map → + Track XLV →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
ETF / Index Composite — N/A for Fund Structure

Single-issuer corporate Reverse-DCF growth hurdles do not apply to index funds or ETFs.

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on XLV today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for XLV. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for XLV today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (XLV)

ETF / Index Rank #2 of 40 ⚔️ DIA vs XLV Full Matrix →

1. Head-to-Head ETF / Index Peer Comparison (XLV vs. DIA, JEPI, XLE, XLF)

Industry: GICS Health Care & Pharma (1 Tracked Issuers)

Across 40 tracked ETF / Index securities in the Roarable RQD universe, Health Care Select Sector SPDR Fund (XLV) ranks #2 by composite RQD confidence (79/100, grade B+) and #13 by equity capitalization ($40.00B). Within this direct 5-issuer industry benchmark cohort, XLV leads on earnings valuation at N/A trailing P/E, while XLV leads on capital efficiency and profitability with ETF composite structure and benchmark tracking. XLV currently leads its immediate peer cohort in composite quantitative strength at 79/100 (B+).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
XLV ACTIVE
Health Care Select Sector SPDR Fund
B+ 79/100 — — — +0.45% $40.00B Benchmark Subject
DIA
SPDR Dow Jones Industrial Average ETF
C 65/100 — — — -1.08% $38.00B /dia-vs-xlv →
JEPI
JPMorgan Equity Premium Income ETF
C 62/100 — — — -0.64% $37.00B /jepi-vs-xlv →
XLE
Energy Select Sector SPDR Fund
B+ 76/100 — — — +1.87% $36.00B /xle-vs-xlv →
XLF
Financial Select Sector SPDR Fund
B 74/100 — — — -0.76% $48.00B /xlf-vs-xlv →

2. XLV ETF Structure, Technical Regime & Benchmark Role Breakdown

EXCHANGE-TRADED FUND / COMPOSITE VEHICLE • NYSE

Because Health Care Select Sector SPDR Fund (XLV) is structured as an exchange-traded fund / composite basket rather than a single operating corporation filing 10-K GAAP income statements, Roarable evaluates XLV on technical trend regime, moving-average dispersion, 52-week range positioning, relative strength (RSI-14), and secondary-market share volume liquidity. At $184.60, XLV trades vs. its 50-day SMA of $172.81 and 200-day SMA of $159.10 on daily liquidity of 18,674,869 shares.

50D SMA Level
$172.81
Medium-Term Trend Anchor
200D SMA Level
$159.10
Institutional Secular Line
52-Week Range Pos
93.0%
$141.97 – $187.99
RSI-14 Momentum
71.4
OVERBOUGHT (>70)
Volume Liquidity
18,674,869
AUM Cap $40.00B

3. XLV Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is XLV stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Health Care Select Sector SPDR Fund (NYSE: XLV) is rated B+ (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 79/100 at a spot price of $184.60 (+0.45% 1D, market cap $40.00B). Pillar breakdown: Fundamental Cash Engine 20/20, Institutional 13F & Options Flow 15/20, SEC Balance-Sheet Forensics 18/20, FRED Macro Regime Fit 11/20, and Executive Insider Alignment 15/20. Across 40 tracked ETF / Index issuers, XLV ranks #2 in composite RQD confidence.

How does XLV compare to DIA and JEPI in the ETF / Index sector?

Within the ETF / Index sector (GICS Health Care & Pharma), XLV carries a Roarable B+ (79/100 RQD), trailing P/E of N/A, gross margin of N/A (ETF), and ROIC of N/A (ETF). By comparison, DIA (SPDR Dow Jones Industrial Average ETF) holds a C grade (65/100 RQD, P/E N/A, ROIC —, cap $38.00B) and JEPI (JPMorgan Equity Premium Income ETF) posts a C grade (62/100 RQD, P/E N/A, ROIC —, cap $37.00B). Among the 5-stock peer group, XLV leads on earnings multiple (N/A) while XLV leads on capital efficiency (— ROIC).

What are the biggest fundamental strengths and SEC risk factors for XLV?

For Health Care Select Sector SPDR Fund (XLV), key quantitative strengths include Diversified GICS Health Care & Pharma basket eliminates single-company earnings blowup risk and Institutional 13F desks and index options flow show constructive basket demand., while primary risk factors center on Corporate GAAP gross margin, Altman-Z, and Form 4 insider metrics are N/A for ETF fund structures and Underlying index basket remains sensitive to Federal Reserve liquidity and Treasury yield swings.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is XLV trading relative to its 50-day, 200-day, and 52-week technical levels?

XLV last traded at $184.60 (+0.45% on volume of 18,674,869 shares), positioning the stock +6.82% above its 50-day simple moving average ($172.81) and +16.03% above its 200-day simple moving average ($159.10). Across its 52-week range of $141.97 to $187.99, XLV sits at the 92.6% percentile with a 14-day RSI of 71.4 (OVERBOUGHT (>70)) and an implied next-earnings move of ±3.5% ($178.14 to $191.06).

Direct Sub-Reports: XLV RQD Cockpit XLV 12M Forecast XLV Earnings & Move XLV Dividends & DRIP XLV Insiders & 13F XLV Whale Options XLV Profit Sankey XLV News & Why
ROARABLE RATING BRIEF • RQD 79/100 (B+) ✓ SEC XBRL & RQD VERIFIED

XLV — Health Care Select Sector SPDR Fund: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2026-11-03

1. Roarable Rating Brief: What This Means to a Prospective Investor

Health Care Select Sector SPDR Fund (XLV) earns a live Roarable RQD composite score of 79/100, corresponding to a B+ letter grade (Roarable Buy) at a spot price of $184.60 (+0.45% 1D, market capitalization $40.00B).

  • Fundamental Cash Engine (20/20): Anchored by return on invested capital (ROIC) of —, gross margin of —, operating margin of —, and free cash flow yield of —.
  • Whale 13F & Options Flow (15/20) + Insider Conviction (15/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (11/20) + Forensic Balance Sheet (18/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of N/A, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

. The fund is described as a liquid institutional exchange-traded fund tracking GICS Health Care & Pharma with approximately $40.0B in assets under management.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (B+ • RQD 79/100): Diversified GICS Health Care & Pharma basket eliminates single-company earnings blowup risk. Institutional 13F desks and index options flow show constructive basket demand. With Fundamental Cash Engine at 20/20 and Institutional Whale Flow at 15/20, sustained execution supports upside toward the upper end of the $141.97 – $187.99 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Corporate GAAP gross margin, Altman-Z, and Form 4 insider metrics are N/A for ETF fund structures. Investors must weigh current valuation against — operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

The source data therefore does not establish upstream suppliers, downstream customers, or 2nd-order bottlenecks. A prospective investor should treat this section as unresolved rather than as evidence of low ripple risk.

  • Key Question #1: Can XLV sustain or expand its — operating margin and — ROIC against GICS Health Care & Pharma peers over the next 4 quarters?
  • Key Question #2: Will free cash flow conversion (— FCF yield) strengthen balance-sheet liquidity (Altman Z-Score N/A) toward the $187.99 52-week high?
  • Key Question #3: How sensitive is XLV's equity valuation to ETF / Index capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

XLV Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Health Care Select Sector SPDR Fund (XLV) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to XLV Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

XLV Bull vs. Bear Conversation Board — What's Your Call at $184.60?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON XLV 🐻 33% BEARISH CONVICTION
1. Pick Your Side on XLV:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
AL AlphaFlow_Cap RQD DEBATE OPENER • Verified $100K Arena Trader 🐂 BULLISH 🎯 Target: $219.67 (+19.0%)
📌 Pinned Debate

Per the RQD rating, the Fundamental Cash Engine and Forensic Balance Sheet pillars score 20/20 and 18/20, and the fund is labeled a Roa

Don't sleep on XLV's setup in ETF / Index. Per the RQD rating, the Fundamental Cash Engine and Forensic Balance Sheet pillars score 20/20 and 18/20, and the fund is labeled a Roarable Buy supported by institutional inflow signals.. Beta of 1.0 means it moves fast when momentum turns, and the 5-pillar RQD gauge (79/100) backs up the fundamental quality.

SectorRotator 🐂 BULL

@AlphaFlow_Cap Agree on the RQD 79/100 quality, though with 1.0 beta I'm scaling in with half-size at $184.60 and keeping dry powder in case we test $171.68.

SH ShortSeller_Dan RQD DEBATE OPENER • Forensic Short Bias 🐻 BEARISH 🎯 Target: $145.83 (-21.0%)
Spot @ $184.60

Valuation & margin reality check on XLV at $184.60 before chasing here

Here is the bear case nobody on the bull side wants to address on XLV: Valuation & margin reality check on XLV at $184.60 before chasing here. At current EV/EBITDA multiples, even a small guidance miss in GICS Health Care & Pharma triggers a 12-15% air pocket.

LIVE TAPE